Form EFFECT Oruka Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 27, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BOC Group Named a Challenger in the 2026 Gartner® Magic Quadrant™ for Digital Twin of an Organization Platforms
- Catalyst by Zoho Solves The Shortfalls of Moving from Coding to Production With an Agent-Ready, Full-Stack Cloud and Built-In Governance
- Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
